Featuring comments from other journals, universities, and news organizations
See also "In the News" and "Dr. Byrareddy’s COVID-19 research" for recent highlights.
Possible HIV breakthrough published in Science
Emory University public relations via UNMC Today | October 14, 2016
Sustained virologic control in SIV+ macaques after antiretroviral and a4b7 antibody therapy
Science | October 14 2016; 354(6309):197-202
Under the Microscope: Promising HIV research
UNMC Today | December 8, 2016
Kolar scientist part of US team researching on remedy for HIV
Deccan Herald | December 1, 2016
Antibody therapy leads to sustains post-treatment SIV control in macaques
i-base | HIV Bulletin | November 29, 2016
Simplifying HIV Treatment: A Surprising New Lead
NIH Director's Blog | November 1, 2016
What Is The Current State Of The HIV Cure?
Forbes | October 31, 2016
Sustained SIV remission achieved in monkeys
NIH Research Matters | October 25, 2016
In Other News
Emory University - Center for AIDS Research | October 18-25, 2016
Intriguing Monkey Study Suggests New Approach to HIV Cure
NEJM Journal Watch | October 18, 2016
Therapy sends monkeys into remission, raises hope of cure
Omaha World-Herald/The Los Angeles Times | October 17, 2016
Researchers Observe Sustained Remission in Monkeys with HIV-Like Virus
HIVandHepatitis.com | October 16, 2016
New antibody therapy permanently blocks SIV infection
innovations report | October 14, 2016
New therapy for HIV on the horizon
Nature India | October 14, 2016
Shock and kill with caution, Perspective; Robert C. Gallo
Science | October 14, 2016
Scientists achieve sustained remission in SIV infection
Emory News Center | October 13, 2016
By adding an antibody to HIV treatment, researchers send virus into 'sustained remission' in monkeys
Los Angeles Time | October 13, 2016
The Scientist | October 13, 2016
Clinicaltrials.gov | September 2016
Dr. Byrareddy's lab & COVID-19
Learn about COVID-19 research by Dr. Byrareddy and his laboratory.
#CannX lecture by Dr. Byrareddy
“Cannabinoids as Adjunct Anti-Viral Therapy for Inflammation Associated with SARS-COV-2”
MIS-C in pediatric cases of COVID-19
Paper suggests cause for COVID-19's aftereffects in children.